These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19578532)

  • 1. Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology.
    Kovatchev B; Clarke W
    J Diabetes Sci Technol; 2008 Jan; 2(1):158-63. PubMed ID: 19578532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes.
    Kovatchev B; Breton M; Clarke W
    Methods Enzymol; 2009; 454():69-86. PubMed ID: 19216923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis, modeling, and simulation of the accuracy of continuous glucose sensors.
    Breton M; Kovatchev B
    J Diabetes Sci Technol; 2008 Sep; 2(5):853-62. PubMed ID: 19750186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System.
    McGarraugh G; Bergenstal R
    Diabetes Technol Ther; 2009 Mar; 11(3):145-50. PubMed ID: 19216686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical information provided by the FreeStyle Navigator continuous interstitial glucose monitor versus traditional blood glucose readings.
    McGarraugh GV; Clarke WL; Kovatchev BP
    Diabetes Technol Ther; 2010 May; 12(5):365-71. PubMed ID: 20388046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed
    Cordero TL; Garg SK; Brazg R; Bailey TS; Shin J; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2017 Dec; 19(12):749-752. PubMed ID: 29148821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.
    Kovatchev BP; Breton M; Man CD; Cobelli C
    J Diabetes Sci Technol; 2009 Jan; 3(1):44-55. PubMed ID: 19444330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis.
    Clarke WL; Anderson S; Farhy L; Breton M; Gonder-Frederick L; Cox D; Kovatchev B
    Diabetes Care; 2005 Oct; 28(10):2412-7. PubMed ID: 16186272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing the Use of CGM Devices in a Non-ICU Setting.
    Wang M; Singh LG; Spanakis EK
    J Diabetes Sci Technol; 2019 Jul; 13(4):674-681. PubMed ID: 30636449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study.
    Basu A; Veettil S; Dyer R; Peyser T; Basu R
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S243-7. PubMed ID: 26784129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphical and numerical evaluation of continuous glucose sensing time lag.
    Kovatchev BP; Shields D; Breton M
    Diabetes Technol Ther; 2009 Mar; 11(3):139-43. PubMed ID: 19216687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INTEGRATED INSULIN PUMP AND CONTINUOUS GLUCOSE MONITORING TECHNOLOGY IN DIABETES CARE TODAY: A PERSPECTIVE OF REAL-LIFE EXPERIENCE WITH THE MINIMED
    Aleppo G; Webb KM
    Endocr Pract; 2018 Jul; 24(7):684-692. PubMed ID: 30048171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alarm characterization for a continuous glucose monitor that replaces traditional blood glucose monitoring.
    McGarraugh G
    J Diabetes Sci Technol; 2010 Jan; 4(1):49-56. PubMed ID: 20167167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.